pharmaceuticals
Belarus antimonopoly officers underwent training at the Federal Antimonopoly Service (FAS Russia)
more
03.04.2017
Competition authorities should approximate their national regulations of pharmaceutical markets more
It is a pressing issue due to the global interest in accessibility of medicinal drugs and fair competition under intensifying innovative activities of pharmaceutical companies
more
23.03.2017
Cassation Court pronounced legitimacy of FAS refusal to increase threefold prices for “Prostenongel” medicinal drugmore
Earlier Courts of two instances confirmed legitimacy of the efforts of the antimonopoly body and the rightness of applying the established requirements to register prices for vital and essential drugs
more
The Office of the Antimonopoly Serve in the Ryazan region found elements of cartel in bidding
more
Pharmaceutical companies continue reducing drug prices upon the findings of an international comparative survey carried out by FAS
more